Trofima Corporation – Trademark Portfolio
Entity Type: 03
Trofima Corporation holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 30 (Staple Foods) — 13 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DEL PATIO, BACK TO NATURE, and DEL PATIO CAFÉ MOLIDO CAFÉ 100% PURO EL CAFÉ DEL PUEBLO. The owner is based in Guaynabo, PR.
Parque Industrial Amelia
Calle Claudia #9, Esq. Beatriz
Guaynabo, PR 00968
Showing of trademarks Trademarks
Trademark Classifications
Trofima Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Frequently Asked Questions
How many trademarks does Trofima Corporation have?
Trofima Corporation has 14 U.S. trademarks filed with the USPTO. Of these, 3 registered, 4 abandoned, 7 cancelled.
What trademark classes does Trofima Corporation file in?
Trofima Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 30 (Staple Foods), Class 32 (Light Beverages). Class 30 covers coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations.
What are Trofima Corporation's most well-known trademarks?
Trofima Corporation's registered trademark portfolio includes well-known marks such as DEL PATIO, BACK TO NATURE, and DEL PATIO CAFÉ MOLIDO CAFÉ 100% PURO EL CAFÉ DEL PUEBLO. These are among 3 currently registered trademarks in the portfolio.
What is Trofima Corporation's trademark registration success rate?
Trofima Corporation has a 21% trademark registration rate, with 3 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.